Tuesday, March 07, 2017
Bayer's White Paper Helps Cucumber Growers Optimize Their High-Wire CultivationNunhem (Netherlands).
What is high-wire cultivation of cucumbers all about? What are the advantages and disadvantages? And how can growers make sure the process is at its most efficient? The answers to these questions can be found in vegetable seed specialist Bayer's white paper on the high-wire cultivation of long cucumbers. This practical guide is the first in a series of white papers entitled “The Only Way Is Up.” Bayer will use these white papers to share its global expertise and to support growers in optimizing process efficiency.
Current market circumstances such as rising labor costs and the demand for reliable, high-quality products all year round have led to a dramatic growth in high-wire cultivation of cucumbers in recent years. Growers rate in particular the reliability of the cultivation system, higher yield, consistent quality, and ease of planning cultivation. Currently, around 19% of long cucumbers are grown using high-wire cultivation. Bayer expects this proportion to grow to at least 30% in the coming five years, with growers in Northern Europe, Canada, and Russia most likely to make the transition.
White Paper As Practical Guide for Growers
The first white paper in the “The Only Way Is Up” series caters to budding and experienced high-wire growers alike who would like to get more out of their cultivation process of long cucumbers. However, the white paper also contains valuable pieces of information for public relations officials, traders, and retailers.
Since high wire cucumber cultivation has been receiving a serious boost in the Netherlands in 2009, Bayer actively develops specialized high wire genetics and cultivation technologies. The Nunhems HiRevolution varieties are one of the driving factors. Their groundbreaking “COMPACT” gene results in open, labor-friendly crops with a high yield and exceptional, uniform fruit quality. These characteristics make these small-leaf varieties particularly well-suited to high-wire cultivation. Bayer is now sharing its extensive knowledge and field insights in a white paper as a market leader in the Netherlands and ambassador of high-wire cultivation areas across the globe.
Future Editions of White Papers
The following two editions in the “The Only Way Is Up” series are already in the pipeline and will focus on short cucumbers and the use of artificial light in high-wire cultivation. There will also be special editions covering subjects that are relevant for other interested parties in the chain, such as traders and retailers.
For information, please contact:
- Cees Ammerlaan
Mobile +31 6 150 04 979, e-mail: email@example.com
- Jan Hanemaaijer
Mobile +31 6 286 08 990, e-mail: firstname.lastname@example.org
- Paul Posthoorn
Mobile +31 6 546 68 761, e-mail: email@example.com
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
Forward Looking Statements
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.